U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia

U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia

August 11, 2022
Naprotek, a Portfolio Company of Edgewater Capital Partners, Acquires MicroFab

Naprotek, a Portfolio Company of Edgewater Capital Partners, Acquires MicroFab

August 9, 2022
Dr. Vince Clinical Research Hires Two Industry Veterans, Bringing Over 50 Years’ Combined Research Experience

Dr. Vince Clinical Research Hires Two Industry Veterans, Bringing Over 50 Years’ Combined Research Experience

July 26, 2022
Cell and Gene Therapy Industry Comes Together for Matica Bio’s New Global Event

Cell and Gene Therapy Industry Comes Together for Matica Bio’s New Global Event

July 21, 2022
<strong>U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business</strong>

U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business

July 13, 2022
Kearney Family YMCA Awarded $4.5 Million Grant Toward Expansion

Kearney Family YMCA Awarded $4.5 Million Grant Toward Expansion

July 6, 2022
The 3rd Annual MedExecWomen Meeting: Strategy, Vision, and Energy

The 3rd Annual MedExecWomen Meeting: Strategy, Vision, and Energy

July 6, 2022
MedExecWomen Third Annual Conference in Boston, June 14, 2022

MedExecWomen Third Annual Conference in Boston, June 14, 2022

May 24, 2022
Veranex Announces Strategic Investments From Accelmed Partners and Lauxera Capital Partners

Veranex Announces Strategic Investments From Accelmed Partners and Lauxera Capital Partners

May 19, 2022
Elligo Launches European Operations to Enable Research Through Healthcare

Elligo Launches European Operations to Enable Research Through Healthcare

May 3, 2022